Search Within

Eytan Moshe Stein

Formats
  1. Meeting Abstract (217)
  2. Journal Article (109)
  3. Review (18)
  4. Research Letter (14)
  5. Editorial (6)
  6. Book Section (3)
  7. Guidelines (2)
  8. Correspondence (1)
  9. Miscellaneous (1)
Groups
  1. Adult Leukemia (371)
  2. Center for Hematologic Malignancies (371)
  3. Department of Medicine (371)
  4. Hematologic Malignancies, Division of (371)
  5. Hematology-Oncology Fellows (111)
  6. GSK Faculty (92)

More Groups

People
  1. Martin Tallman (118)
  2. Ross Levine (75)
  3. Aaron Goldberg (43)
  4. Andriy Derkach (33)
  5. Jan Bewersdorf (33)
  6. Christopher Famulare (31)

More People

Years
  1. 2025 (20)
  2. 2024 (45)
  3. 2023 (49)
  4. 2022 (34)
  5. 2021 (31)
  6. 2020 (30)

More Years

Publications
  1. Blood (171)
  2. Journal of Clinical Oncology (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (18)
  4. Haematologica (16)
  5. Blood Advances (14)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (186)
  2. Elsevier Inc. (32)
  3. American Society of Clinical Oncology (28)
  4. Ferrata Storti Foundation (16)
  5. Nature Publishing Group (15)
  6. Taylor & Francis Group (12)

More Publishers

Results (371)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A precision medicine classification for treatment of acute myeloid leukemia in older patients
    Journal Article

    Mims, A. S.; Kohlschmidt, J.; Borate, U.; Blachly, J. S.; Orwick, S.; Eisfeld, A. K.; Papaioannou, D.; Nicolet, D.; Mrόzek, K.; Stein, E.; more...
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: A SEER-Medicare analysis
    Journal Article

    Stein, E. M.; Bonifacio, G.; Latremouille-Viau, D.; Shi, S.; Guerin, A.; Wu, E. Q.; Sadek, I.; Cao, X.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML
    Research Letter

    Mason, E. F.; Pozdnyakova, O.; Roshal, M.; Fathi, A. T.; Stein, E. M.; Ferrell, P. B.; Shaver, A. C.; Frattini, M.; Wang, H.; Hua, L.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: A phase 1 study
    Journal Article

    Stein, E. M.; DiNardo, C. D.; Fathi, A. T.; Mims, A. S.; Pratz, K. W.; Savona, M. R.; Stein, A. S.; Stone, R. M.; Winer, E. S.; Seet, C. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia
    Review

    Fathi, A. T.; Stein, E. M.; DiNardo, C. D.; Levis, M. J.; Montesinos, P.; de Botton, S.
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: A SEER-Medicare analysis
    Journal Article

    Stein, E. M.; Bonifacio, G.; Latrémouille-Viau, D.; Shi, S.; Guérin, A.; Wu, E. Q.; Sadek, I.; Cao, X.
    Journal of Medical Economics (2021)

    Fulltext@MSK | Save
  • Mutant isocitrate dehydrogenase 1 inhibitor ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia
    Journal Article

    DiNardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; Döhner, H.; Martinelli, G.; Patel, P. A.; Raffoux, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase 1 study of LY3410738, a first-in-class covalent inhibitor of mutant IDH in advanced myeloid malignancies (trial in progress)
    Meeting Abstract

    Stein, E. M.; Konopleva, M.; Gilmour, R.; Szpurka, A. M.; Hill, E.; Ward, R.; Kantarjian, H. M.; Dinardo, C. D.
    Blood (2020)

    Fulltext@MSK | Save